Linear Clinical Research

Are you aged 18–65 and living in Perth? 📍

You may be eligible to take part in The Blood Flow Study, a clinical trial researching a potential new treatment for the prevention of thromboembolic events (blood clots).

Blood clots can lead to serious health complications, and studies like this help researchers better understand potential new treatment options. By participating, you’ll be contributing to meaningful medical research while being compensated for your time and commitment. 💙

Be part of research that could help shape the future of healthcare.

🔗 https://www.linear.org.au/find-trials/the-blood-flow-study/

Did you know? Clinical Trials Day marks the date of the world's first controlled clinical trial, conducted in 1747 by a naval surgeon named James Lind.

Fast-forward 278 years, and trials are how every medicine you've ever taken got onto your pharmacy shelf.

At Linear, we're proud to be part of that chain, with world-class facilities right here in Perth, WA.

We asked one of our Senior Research Physicians at Linear, Dr Peter Schrader to reflect on his experience working in clinical trials and what continues to motivate him after nine years in the field:

"𝘖𝘯𝘦 𝘵𝘩𝘪𝘯𝘨 𝘵𝘩𝘢𝘵 𝘪𝘯𝘵𝘦𝘳𝘦𝘴𝘵𝘴 𝘮𝘦 𝘢𝘣𝘰𝘶𝘵 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘵𝘳𝘪𝘢𝘭𝘴 𝘪𝘴 𝘰𝘣𝘵𝘢𝘪𝘯𝘪𝘯𝘨 𝘢𝘯𝘥 𝘢𝘯𝘢𝘭𝘺𝘴𝘪𝘯𝘨 𝘥𝘢𝘵𝘢 𝘸𝘩𝘪𝘤𝘩 𝘦𝘮𝘦𝘳𝘨𝘦𝘴 𝘸𝘩𝘦𝘯 𝘢 𝘯𝘦𝘸 𝘥𝘳𝘶𝘨 𝘪𝘴 𝘨𝘪𝘷𝘦𝘯 𝘵𝘰 𝘩𝘶𝘮𝘢𝘯𝘴, 𝘦𝘴𝘱𝘦𝘤𝘪𝘢𝘭𝘭𝘺 𝘪𝘯 𝘧𝘪𝘳𝘴𝘵-𝘪𝘯-𝘩𝘶𝘮𝘢𝘯 𝘵𝘳𝘪𝘢𝘭𝘴. 𝘐𝘵 𝘪𝘴 𝘢𝘭𝘴𝘰 𝘳𝘦𝘸𝘢𝘳𝘥𝘪𝘯𝘨 𝘵𝘰 𝘴𝘦𝘦 𝘯𝘦𝘸 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴 𝘣𝘦𝘤𝘰𝘮𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘵𝘰 𝘱𝘢𝘵𝘪𝘦𝘯𝘵𝘴 𝘸𝘩𝘰 𝘮𝘢𝘺 𝘩𝘢𝘷𝘦 𝘭𝘪𝘮𝘪𝘵𝘦𝘥 𝘰𝘵𝘩𝘦𝘳 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘰𝘱𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦𝘪𝘳 𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯."

Trials don't advance medicine. People do.
Today we celebrate ours.

World Immunisation Week

Vaccines help protect against more than 30 life-threatening diseases and infections.

They remain one of the most effective ways to protect not just ourselves, but our communities too, helping reduce the spread and impact of serious illnesses.

At Linear Clinical Research, since 2010 we’ve conducted over 500 clinical trials, including 18 vaccine studies, supporting the development of new and improved vaccines.

Be part of advancing future vaccines by joining one of our current studies:
• Meningococcal B Vaccine Study
• Respiratory Virus Vaccine Study

If you’re interested in contributing to future medical advancements, you can learn more and see if you’re eligible to take part.

𝐉𝐨𝐢𝐧 𝐭𝐡𝐞 𝐁𝐚𝐥𝐚𝐧𝐜𝐞 𝐒𝐭𝐮𝐝𝐲 | Participate in 𝐖𝐞𝐢𝐠𝐡𝐭 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Are you 18–65, living in Perth, and have a BMI between 22–40? Join our new trial and help Perth researchers explore a potential new treatment for weight management.
⁣⁣
This investigational treatment is designed to work with natural hormones that control appetite and blood sugar, helping people feel fuller and supporting healthy weight and blood sugar levels.

Start your journey today and become an integral part of this important study: https://www.linear.org.au/find-trials/the-balance-study/

Are you a healthy male aged 18–55, living in Perth, with a BMI between 18.5 and 32?
You may be eligible to take part in a medical research study exploring a potential new treatment for pain relief associated with surgical procedures.
By joining the study, you’ll play an important role in potentially advancing medical research and supporting the development of future healthcare solutions.
Take part today and make a meaningful contribution to the future of healthcare.
🔗 https://www.linear.org.au/find-trials/the-pain-relief-study/

It was great to be at UWA Careers Fair this week connecting with students and sharing insights into clinical research and the many pathways into the industry.

Always a pleasure engaging with the next generation of local talent and seeing strong interest in how medical research careers can make an impact 🫶

👉 Discover more about Linear: https://www.linear.org.au/

You may be eligible to take part in a medical research study evaluating a potential treatment for Alternating Hemiplegia of Childhood (AHC).
If you are between 18 and 65, living in Perth, and have a BMI between 18.5 and 32, you may qualify to participate.
By joining the study, you’ll play an important role in helping advance research for AHC while being reimbursed for your time and commitment.
Take part in research that could potentially help shape the future of treatment and support those living with rare neurological conditions.
🔗 https://www.linear.org.au/find-trials/the-ahc-study/

On Rare Disease Day, we stand alongside the millions of individuals and families living with rare conditions, communities defined by resilience, urgency, and hope.

Today, we’re highlighting a collaboration grounded in science and shared purpose: Linear Clinical Research, EyeXcel, and The Usher III Initiative, working together to advance a potential treatment for Usher Syndrome Type III (USH3).

USH3 is a rare inherited disorder caused by mutations in the Clarin-1 gene, leading to progressive hearing and visual loss in childhood or adolescence. With no approved therapies, patients and families face a relentless disease course and limited options.

For more than 27 years, this program has been driven by scientific persistence and deeply personal commitment. EyeXcel’s president and co-founder, Cindy Elden, lives with USH3 herself, making this effort not just scientific innovation but a mission shaped by lived experience, and determination to change the future for others affected by the disease. After screening thousands of compounds, BF844 was identified and optimised. It underwent extensive preclinical testing to evaluate safety and efficacy. Together with Linear, EyeXcel has successfully completed Phase 1 human safety trials in healthy volunteers, a key milestone in developing a potential therapy for this rare disease.

Completion of Phase 1 enables progression to Phase 2 studies in individuals living with USH3 and reflects the impact of sustained collaboration across industry, academia, philanthropy, and clinical research.

At Linear, we’re honoured to be part of this journey, advancing rare disease research and advancing hope. 💜

You may be eligible to take part in a medical research study testing a potential treatment for the treatment of Transthyretin Amyloid Cardiomyopathy.

By joining the study, you’ll play an important role in advancing medical research and be rewarded for your time and commitment.

Join the study today and make a meaningful contribution to the future of healthcare.

🔗Link in Bio